Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients

(2015) Stephen E. Lincoln et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry

(2014) Eric Rosenthal et al.   BREAST CANCER RESEARCH AND TREATMENT

Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel

(2014) Nadine Tung et al.   CANCER

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes

(2014) Laurent Castéra et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

(2014) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

To Reflex or Not: Additional BRCA1/2 Testing in Ashkenazi Jewish Individuals Without Founder Mutations

(2014) Nancie Petrucelli et al.   Journal of Genetic Counseling

The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?

(2013) FSM Hilbers et al.   CLINICAL GENETICS

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel

(2012) Yael Laitman et al.   BREAST CANCER RESEARCH AND TREATMENT

Germline mutations in RAD51C in Jewish high cancer risk families

(2012) Anya Kushnir et al.   BREAST CANCER RESEARCH AND TREATMENT

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families

(2012) Irene Catucci et al.   Familial Cancer

RAD51C is a susceptibility gene for ovarian cancer

(2011) Liisa M. Pelttari et al.   HUMAN MOLECULAR GENETICS

Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence

(2011) Ben Zhang et al.   LANCET ONCOLOGY

Association between ATM polymorphisms and cancer risk: a meta-analysis

(2011) Li Shen et al.   MOLECULAR BIOLOGY REPORTS

Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel

(2010) Yael Laitman et al.   BREAST CANCER RESEARCH AND TREATMENT

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

(2010) Nancie Petrucelli et al.   GENETICS IN MEDICINE

Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer

(2009) Sean V. Tavtigian et al.   AMERICAN JOURNAL OF HUMAN GENETICS

The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families

(2008) M. D. Palma et al.   CANCER RESEARCH